Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus
Authors:
- Mustafa Erkan SarıMSMustafa Erkan Sarı
- Mehmet Mutlu MeydanlıMMMehmet Mutlu Meydanlı
- Ibrahim YalçınIYIbrahim Yalçın
- Hanifi ŞahinHŞHanifi Şahin
- Gonca ÇobanGÇGonca Çoban
- Hüsnü ÇelikHÇHüsnü Çelik
- Esra KuşçuEKEsra Kuşçu
- Tayfun GungorTGTayfun Gungor
- Ali AyhanAAAli Ayhan
- 13 November 2018
- journal article
- research article
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 41 (12) , 750-754
Abstract
Introduction: We aimed to assess risk factors for lymph node (LN) metastasis among lymphovascular space invasion(LVSI)-positive women with pure endometrioid endometrial cancer (EC) clinically confined to the uterus. Methods: Medical records of women who underwent primary surgery for EC between 2007 and 2016 at either of 2 gynecological oncology centers were retrospectively reviewed. Patient data were analyzed with respect to LN involvement, and predictive factors for LN metastasis were investigated. Results: 280 patients with surgically staged endometrioid-type EC with LVSI were identified. LN involvement was detected in 88 patients (31.4%) with a systematic LN dissection. In multivariate analysis, elevated baseline serum CA 125 levels, deep myometrial invasion (MMI), adnexal involvement and positive peritoneal cytology were found to be independent risk factors for LN metastasis. In women without deep MMI and elevated baseline serum CA 125 levels, the rate of LN metastasis was 19%. The presence of solely deep MMI increased this probability up to 29.1%. The rate of LN metastasis was found to be 46.8% for women with both deep MMI and elevated baseline serum CA 125 levels. Conclusion: These findings may be useful in the decision-making process for LVSI-positive women who are unstaged.Keywords
This publication has 27 references indexed in Scilit:
- The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometriumGynecologic Oncology, 2012
- Lymph-Vascular Space Invasion as a Significant Risk Factor for Isolated Para-aortic Lymph Node Metastasis in Endometrial Cancer: A Study of 203 Consecutive PatientsAnnals of Surgical Oncology, 2010
- Clinical Value of Immunohistochemically Detected Lymphatic and Vascular Invasions in Clinically Staged Endometrioid Endometrial CancerInternational Journal of Gynecological Cancer, 2009
- Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinomaGynecologic Oncology, 2007
- Carcinoma of the Corpus UteriInternational Journal of Gynecology & Obstetrics, 2006
- Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancerInternational Journal of Gynecological Cancer, 2006
- Lymphvascular space involvement: an independent prognostic factor in endometrial cancerGynecologic Oncology, 2005
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer?Gynecologic Oncology, 2002
- Predictors of Lymphatic Failure in Endometrial CancerGynecologic Oncology, 2002